STOCK TITAN

Gallagher (ARTHUR J.) & Co. SEC Filings

AJG NYSE

Welcome to our dedicated page for Gallagher (ARTHUR J.) & Co. SEC filings (Ticker: AJG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Arthur J. Gallagher & Co.’s story is written one acquisition and policy renewal at a time, which makes its SEC documents a treasure trove for anyone tracking brokerage commission growth or employee-benefit margins. Whether you need the latest goodwill roll-forward from an annual report 10-K or want to confirm how many agencies AJG bought last quarter, every detail lives inside the filings you’ll find here.

Stock Titan’s platform turns those dense disclosures into plain English. Our AI produces bite-size summaries that answer common searches such as “Arthur J. Gallagher SEC filings explained simply” or “understanding AJG 8-K material events”. You’ll see real-time alerts the moment an Arthur J. Gallagher Form 4 insider transactions notice hits EDGAR, compare segment revenue inside the Arthur J. Gallagher quarterly earnings report 10-Q filing, and unpack board pay from the proxy statement executive compensation. Each document page links directly to highlighted passages so analysts spend minutes, not hours, locating key numbers.

All filing types are covered and searchable:

  • 10-K: acquisition strategy, contingent commissions, and reserve sensitivity—Arthur J. Gallagher annual report 10-K simplified
  • 10-Q: seasonal premium flows and organic growth—AJG earnings report filing analysis
  • 8-K: brokerage divestitures or leadership changes—AJG 8-K material events explained
  • Form 4: executive stock trades with Arthur J. Gallagher Form 4 insider transactions real-time

Use these insights to monitor insider buying before renewal season, gauge risk-management fee trends, or benchmark cash flows against peers. Complex insurance brokerage disclosures are finally clear, current, and actionable—thanks to AI guidance and instant SEC feeds.

Rhea-AI Summary

Arthur J. Gallagher & Co. insider filing reports that Douglas K. Howell, Vice President & Chief Financial Officer, sold 3,000 shares of AJG common stock on 09/09/2025 at an average weighted price of $299.778 per share (sales ranged $299.47–$299.89). After the sale he directly beneficially owned 114,776.7558 shares, with an additional 3,165 shares held indirectly by his spouse and 418.691 shares in a company 401(k) account.

The filing explains the sale was to cover tax obligations arising from the distribution of 35,739 deferred shares under the company Supplemental Savings and Thrift Plan previously reported on August 4, 2025; in lieu of withholding, he received the full distribution and sold a portion to satisfy taxes. The reporting person disclaims voting or investment power over the spousal-held shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Hudson Scott R, a Vice President at Arthur J. Gallagher & Co. (AJG), reported multiple transactions on 09/08/2025. The filing shows the exercise of a non-qualified stock option for 7,600 shares at an exercise price of $79.59, creating ownership of 7,600 shares underlying the option and increasing reported beneficial holdings to 93,520 shares. The same day the report records sales: 7,600 shares sold at an average price of $297.5133 and 5,255 shares sold at $297.733, with reported beneficial ownership after sales at 85,920 shares. The report also discloses 339.027 shares held indirectly in a Gallagher 401(k) plan account. The option vests in three equal annual installments beginning on the third anniversary of the grant.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 144 notice for Arthur J. Gallagher & Co. (AJG) shows a proposed sale of 3,000 shares of common stock through Goldman Sachs & Co. LLC on the NYSE with an aggregate market value of $895,500 and approximate sale date 09/09/2025. The filing reports 256,400,000 shares outstanding for the issuer. The 3,000 shares were acquired on 03/15/2025 as restricted stock awards received as compensation and were paid for as compensation. The filer reports no securities sold in the past three months and includes the standard signature representation about absence of undisclosed material adverse information. Several issuer and filer contact fields in the provided content are blank or not completed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Form 144 filed for Arthur J. Gallagher & Co. (AJG) shows a proposed sale of 12,855 common shares with an aggregate market value of $3,825,688.01, against 256,400,000 shares outstanding. The proposed sale date is 09/08/2025 on the NYSE through Fidelity Brokerage Services LLC.

The filing discloses the acquisition history for the shares to be sold: 4,100 shares from restricted stock vesting on 03/15/2025 (compensation), 1,155 shares from a deferred equity participation program on 04/01/2025 (compensation), and 7,600 shares from option exercise (option granted 03/14/2019) with payment in cash on 09/08/2025. The filer reports nothing to report for securities sold in the past three months and affirms no undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

David S. Johnson, a director of Arthur J. Gallagher & Co. (AJG), reported a non-derivative acquisition on 09/01/2025 of 161.024 shares of the company's common stock at a price of $302.75 per share. The filing states this acquisition arose from Mr. Johnson's prior election under the company's Director Deferral Plan to convert his quarterly cash retainer into deferred share units that will be distributed as common stock. After the transaction, Mr. Johnson beneficially owns 45,624.624 shares. The Form 4 was submitted by power of attorney (Monica Norzagaray) and dated 09/03/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Christopher C. Miskel, a director of Arthur J. Gallagher & Co. (AJG), reported a purchase of the issuer's common stock on 09/01/2025 under Form 4. The filing shows a transaction coded A(1) for Common Stock with an amount listed as 132.122 acquired at a price of $302.75. Following the reported transaction the filing lists 8,947.996 shares beneficially owned. The acquisition is explained as a distribution under the company's Director Deferral Plan: the reporting person elected in a prior year to defer quarterly cash retainer payments into deferred share units that will be distributed in common stock. The form is signed by a power of attorney, Monica Norzagaray, on 09/03/2025. The reporting person is identified as a Director of AJG.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Form 4 filing by Richard C. Cary (Controller, CAO and Director) for Arthur J. Gallagher & Co. (AJG). The filing reports a sale of 4,000 shares of common stock on 08/21/2025 at a reported price of $306 per share. After the transaction Mr. Cary is shown as beneficially owning 56,667.789 shares directly plus an indirect holding of 418.699 shares in a Gallagher 401(k) plan account, with reporting handled under power of attorney on 08/22/2025.

The form clarifies reporting format: previously separate Common Stock and Restricted Common Stock lines will be combined going forward. No derivative transactions, acquisitions, grants, or additional disclosures are included in this filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Arthur J. Gallagher & Co. (AJG) Form 4 shows insider transactions by Thomas Joseph Gallagher, an officer (President). On 08/20/2025 he reported dispositions of 875 shares and an acquisition of 375 shares; following those transactions he directly owned 308,046.08 shares and indirectly owned 119,175 shares held by his wife as trustee. On 08/21/2025 there were transfers and transactions resulting in dispositions and acquisitions of 30,000 shares each, and reported indirect holdings across an irrevocable trust, a grantor retained annuity trust (62,295 shares) and a Gallagher 401(k) account (418.7 shares). Explanations state certain shares are held in trusts for his children and that some transfers to an irrevocable trust were for no consideration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 144 notice for Arthur J. Gallagher & Co. (AJG): The filing states a proposed sale of 4,000 common shares$1,224,000, planned for 08/21/2025 on the NYSE. The shares were acquired on 11/05/2024 as a retirement plan distribution from the issuer and were paid as compensation on the same date. The filer reports no securities sold in the past three months.

The filing contains the standard representation that the seller does not possess undisclosed material adverse information about the issuer. Other issuer contact and relationship fields are present but contain no substantive details in the provided content.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
current report

FAQ

What is the current stock price of Gallagher (ARTHUR J.) & Co. (AJG)?

The current stock price of Gallagher (ARTHUR J.) & Co. (AJG) is $253.39 as of December 19, 2025.

What is the market cap of Gallagher (ARTHUR J.) & Co. (AJG)?

The market cap of Gallagher (ARTHUR J.) & Co. (AJG) is approximately 64.9B.
Gallagher (ARTHUR J.) & Co.

NYSE:AJG

AJG Rankings

AJG Stock Data

64.88B
254.07M
0.92%
91.18%
1.45%
Insurance Brokers
Insurance Agents, Brokers & Service
Link
United States
ROLLING MEADOWS